Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 475 of 2228 entries
View as:

BI836826 Dose Escalation in Relapsed Chronic Lymphocytic Leukaemia (CLL)

Phase: N/A Priority: Normal
NCT ID: NCT01296932 Org: User:
Start: 02/11/11 End: 07/10/17 Due: 07/10/18

Investigation of the Effect of Food on the Bioavailability of a 25 mg Empagliflozin Tablet as Well as Assessment of Dose Proportionality Between 10 mg and 25 mg Empagliflozin Tablets Under Fasting Conditions.

Phase: N/A Priority: Normal
NCT ID: NCT01451775 Org: User:
Start: 10/31/11 End: - Due: -

Safety and Efficacy of Meloxicam Compared to Other Nonsteroidal Antiinflammatory Drugs (NSAIDs) in an Observational Cohort Study of Patients With Rheumatoid Arthritis, Osteoarthritis, Lumbago, Scapulohumeral Periarthritis, Neck, Shoulder and Arm Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT02180516 Org: User:
Start: 10/31/01 End: - Due: -

Clairleafᵀᴹ: A Study to Test Long-term Treatment With BI 1291583 in People With Bronchiectasis Who Took Part in a Previous Study With This Medicine

Phase: N/A Priority: Normal
NCT ID: NCT05846230 Org: User:
Start: 09/08/23 End: 03/31/27 Due: 03/31/28

Dose Finding Study of BI 6727 (Volasertib) in Patients With Various Solid Cancers

Phase: N/A Priority: Normal
NCT ID: NCT00969553 Org: User:
Start: 08/31/09 End: 09/30/11 Due: 09/30/12

Platform Trial Evaluating Safety and Efficacy of BI 754091 Anti- PD-1 Based Combination Therapies in PD-(L)1 naïve and PD- (L)1 Pretreated Patient Populations With Advanced/Metastatic Solid Tumours

Phase: N/A Priority: Normal
NCT ID: NCT03697304 Org: User:
Start: 03/19/19 End: 12/03/24 Due: 12/03/25

A Study of BI 853520 in Patients With Various Types of Advanced or Metastatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01335269 Org: User:
Start: 07/31/11 End: 12/31/15 Due: 12/31/16

Diabetes Study of Linagliptin and Empagliflozin in Children and Adolescents (DINAMO)TM

Phase: N/A Priority: Normal
NCT ID: NCT03429543 Org: User:
Start: 03/20/18 End: 05/31/23 Due: 05/31/24

Pharmacokinetics and Safety of WAL2014 (Talsaclidine) Administered Orally to Healthy Adult Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02264080 Org: User:
Start: 03/31/99 End: - Due: -

Bioavailability of Oral BIRB 796 BS Tablets With and Without Administration of Oral Pantoprazole in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02209831 Org: User:
Start: 11/30/01 End: - Due: -

Preliminary Bioequivalence Study of UHAC 62 XX Tablets Compared With a Capsule Formulation in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02180477 Org: User:
Start: 11/30/01 End: - Due: -

Pharmacokinetics, Safety and Tolerability of Digoxin With or Without Co-administration of BI 1356 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02183402 Org: User:
Start: 06/30/08 End: - Due: -

Oxygen Therapy Use in Patients With Fibrotic Interstitial Lung Disease

Phase: N/A Priority: Normal
NCT ID: NCT05957198 Org: User:
Start: 07/25/23 End: 09/26/23 Due: 09/26/24

PMS Assessing the Long-term Efficacy and Safety of Nevirapine Therapy (Combined With Other ARV Drugs) in HIV-1 Positive Patients in Daily Clinical Practice.

Phase: N/A Priority: Normal
NCT ID: NCT00736502 Org: User:
Start: 09/30/08 End: - Due: -

Pharmacokinetics of BIBR 277 in Hypertensive Patients

Phase: N/A Priority: Normal
NCT ID: NCT02187497 Org: User:
Start: 06/30/98 End: - Due: -

An Exploratory Maintenance Trial of BI 655064 in Patients With Lupus Nephritis

Phase: N/A Priority: Normal
NCT ID: NCT03385564 Org: User:
Start: 01/09/18 End: 07/27/21 Due: 07/27/22

A Study in Healthy People to Compare How 2 Different Low Dose Formulations of BI 1015550 Are Taken up in the Body

Phase: N/A Priority: Normal
NCT ID: NCT06408870 Org: User:
Start: 06/06/24 End: 08/28/24 Due: 08/28/25

Observational Study in Parkinson's Disease of the Primary Care Population of Patients Treated With Pramipexole

Phase: N/A Priority: Normal
NCT ID: NCT02236728 Org: User:
Start: 02/29/08 End: - Due: -

Bioavailability of BIBR 1048 MS Single Doses With or Without Pantoprazole in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02170805 Org: User:
Start: 04/30/01 End: - Due: -

A Study in the United States Using Electronic Medical Records (EMR) to Assess Effectiveness of Afatinib (Gilotrif) Following Pembrolizumab and Chemotherapy in the Treatment of Metastatic Squamous Cell Carcinoma of the Lung

Phase: N/A Priority: Normal
NCT ID: NCT04552535 Org: User:
Start: 05/08/20 End: 05/18/20 Due: 05/18/21

Ketoprofen Lysine Salt as Mouthwash in Acute Phlogosis of the Pharyngeal Cavity Versus Benzidamine Hydrochloride

Phase: N/A Priority: Normal
NCT ID: NCT02178293 Org: User:
Start: 09/30/98 End: - Due: -

Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent® Inhalation Aerosol in COPD Patients.

Phase: N/A Priority: Normal
NCT ID: NCT00388882 Org: User:
Start: 10/04/06 End: - Due: -

Phase II Trial of BIBW 2992 in Patients With HER2-positive Metastatic Breast Cancer After Failure of Trastuzumab Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00431067 Org: User:
Start: 09/30/06 End: - Due: -

Study on BI 54903 (Inhaled Corticosteroid) Administered Once Daily or Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Low Dose Inhaled Corticosteroids

Phase: N/A Priority: Normal
NCT ID: NCT01458912 Org: User:
Start: 11/30/11 End: - Due: -

Observational Study in Patients With Functional Benign Prostatic Hyperplasia Symptoms Who Switched From Phytotherapy to ALNA® (Tamsulosin)

Phase: N/A Priority: Normal
NCT ID: NCT02244320 Org: User:
Start: 09/30/02 End: - Due: -